Recent Advances in the Diagnostic Value of New Biochemical Markers of Sepsis-induced Myocardial Injury

doi:10.12114/j.issn.1007-9572.2020.00.566

Abstract

Abstract: Sepsis-induced myocardial damage（SIMD）can lead to poor prognosis and high mortality，so early identification and active treatment are essential. As traditional biomarkers such as cardiac troponin and brain natriuretic peptide are not specific for SIMD，we reviewed the advances in biomarkers for this disease，with detailed summary of the history，release mechanism and diagnostic value of several novel biomarkers〔miRNAs，heart-type fatty acid binding protein（H-FABP），pregnancy-associated plasma protein A（PAPP-A），histone，high mobility group protein-1（HMGB-1），soluble triggering receptor expressed on myeloid cell-1（sTREM-1），and neutrophil gelatinase-associated lipocalin（NGAL）〕in SIMD，and found that miRNAs may be a good predictor as well as an improvement parameter for SIMD，and H-FABP，PAPPA，histone，HMGB-1，sTREM-1 and NGAL may be predictors for SIMD，but the combination of multiple biomarkers may have higher predictive value. In view of the fact that patient enrolment using the sepsis 1.0 or 2.0 diagnostic criteria in majority of SIMD-related clinical studies，and there are few studies using the current sepsis 3.0 criteria，in the era of sepsis 3.0，the value of above-mentioned biomarkers for SIMD diagnosis may be challenged，and the power of multi-biomarkers to predict SIMD also needs to be re-evaluated using new clinical evaluation methods.

Key words: Sepsis, Myocardial injury, Biomarker, Diagnostic value, Sensitivity, Specificity

摘要： 脓毒症心肌损伤（SIMD）可导致患者出现不良预后和高死亡率，对其早期识别并给予积极的治疗至关重要。B型脑钠肽、心肌肌钙蛋白等传统的心肌损伤标志物对SIMD诊断缺乏特异性，本文通过检索相关文献，介绍了新型生化标志物包括微小RNAs（miRNAs）、心型脂肪酸结合蛋白（H-FABP）、妊娠相关血浆蛋白A（PAPPA）、组蛋白、高迁移率族蛋白（HMGB-1）、可溶性髓样细胞触发受体-1（sTREM-1）、中性粒细胞明胶酶相关载脂蛋白（NGAL）的起源，及其在SIMD中的释放机制，并总结了上述新型生化标志物对SIMD的诊断价值，发现miRNAs不仅对SIMD具有较好的预测价值，同时也可能用于改善SIMD；H-FABP、PAPPA、组蛋白、HMGB-1、sTREM-1、NGAL等新型生化标志物对SIMD均有一定的预测价值，多种标志物组合能够提高对SIMD的诊断能力。鉴于目前多数SIMD相关临床研究患者纳入时采用脓毒症1.0或2.0诊断标准，采用脓毒症3.0诊断标准的研究偏少，在脓毒症3.0诊断时代，上述生化标志物对SIMD的临床诊断价值将受到挑战，多种标志物组合预测SIMD的价值也需要结合新的临床评估手段重新进行评价。

关键词: 脓毒症, 心肌损伤, 生化标志物, 诊断价值, 灵敏度, 特异度

CHEN Fachao,XU Yinchuan,ZHANG Zhaocai. Recent Advances in the Diagnostic Value of New Biochemical Markers of Sepsis-induced Myocardial Injury　[J]. Chinese General Practice, 2021, 24(5): 533-538. DOI: 10.12114/j.issn.1007-9572.2020.00.566.
陈发超,徐银川,张召才. 新型生化标志物在脓毒症心肌损伤中的诊断价值研究进展[J]. 中国全科医学, 2021, 24(5): 533-538. DOI: 10.12114/j.issn.1007-9572.2020.00.566.

References

［1］SINGER M，DEUTSCHMAN C S，SEYMOUR C W，et al．The third international consensus definitions for sepsis and septic shock（sepsis-3）［J］．JAMA，2016，315（8）：801-810．DOI：10.1001/jama.2016.0287.
［2］PERNER A，CECCONI M，CRONHJORT M，et al．Expert statement for the management of hypovolemia in sepsis［J］．Intensive Care Med，2018，44（6）：791-798．DOI：10.1007/s00134-018-5177-x.
［3］ROMERO-BERMEJO F J，RUIZ-BAILEN M，GIL-CEBRIAN J，et al．Sepsis-induced cardiomyopathy［J］．Curr Cardiol Rev，2011，7（3）：163-183．DOI：10.2174/157340311798220494.
［4］MASSON S，CAIRONI P，FANIZZA C，et al．Sequential N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin measurements during albumin replacement in patients with severe Sepsis or septic shock［J］．Crit Care Med，2016，44（4）：707-716．DOI：10.1097/CCM.0000000000001473.
［5］RAJA D C，MEHROTRA S，AGRAWAL A，et al．Cardiac biomarkers and myocardial dysfunction in septicemia［J］．J Assoc Physicians India，2017，65（12）：14-19.
［6］ZHEN J H，LI L，YAN J.Advances in biomarkers of myocardial injury in sepsis［J］．Zhonghua Wei Zhong Bing Ji Jiu Yi Xue，2018，30（7）：699-702．DOI：10.3760/cma.j.issn.2095-4352.2018.07.017.
［7］LEVY M M，FINK M P，MARSHALL J C，et al．2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference［J］．Crit Care Med，2003，31（4）：1250-1256．DOI：10.1097/01.CCM.0000050454.01978.3B.
［8］GUO H L，TANG L Y，XU J J，et al．MicroRNA-495 serves as a diagnostic biomarker in patients with Sepsis and regulates Sepsis-induced inflammation and cardiac dysfunction［J］．Eur J Med Res，2019，24（1）：37．DOI：10.1186/s40001-019-0396-3.
［9］BENZ F，ROY S，TRAUTWEIN C，et al．Circulating MicroRNAs as biomarkers for Sepsis［J］．Int J Mol Sci，2016，17（1）：78．DOI：10.3390/ijms17010078.
［10］MIRNA M，PAAR V，REZAR R，et al．MicroRNAs in inflammatory heart diseases and Sepsis-induced cardiac dysfunction：a potential scope for the future?［J］．Cells，2019，8（11）：E1352．DOI：10.3390/cells8111352.
［11］WANG X H，HUANG W，YANG Y，et al．Loss of duplexmiR-223（5p and 3p）aggravates myocardial depression and mortality in polymicrobial Sepsis［J］．Biochim Biophys Acta，2014，1842（5）：701-711．DOI：10.1016/j.bbadis.2014.01.012.
［12］XIE J，ZHANG L N，FAN X Y，et al．MicroRNA-146a improves Sepsis-induced cardiomyopathy by regulating the TLR-4/NF-κB signaling pathway［J］．Exp Ther Med，2019，18（1）：779-785．DOI：10.3892/etm.2019.7657.
［13］QUAN X H，JI Y Q，ZHANG C Y，et al．Circulating MiR-146a may be a potential biomarker of coronary heart disease in patients with subclinical hypothyroidism［J］．Cell Physiol Biochem，2018，45（1）：226-236．DOI：10.1159/000486769.
［14］WANG H，BEI Y H，SHEN S T，et al．MiR-21-3p controls Sepsis-associated cardiac dysfunction via regulating SORBS2［J］．J Mol Cell Cardiol，2016，94：43-53．DOI：10.1016/j.yjmcc.2016.03.014.
［15］WU Z J，CHEN Y F，WANG H D，et al．Expression of plasma miRNA-497 in children with Sepsis-induced myocardial injury and its clinical significance［J］．Chin J Contemp Pediatr，2018，20（1）：32-36.
［16］薛雨晨，薛晓梅，何斌.微小RNA-133a和微小RNA-499a-5p在脓毒性心肌病中的诊断和预后价值［J］．国际麻醉学与复苏杂志，2019，40（8）：759-764．DOI：10.3760/cma.j.issn.1673-4378.2019.08.011.
XUE Y C，XUE X M，HE B.Diagnostic and predictive value of micro RNA-133a and micro RNA-499a-5p in patients with sepsis induced cardiomyopathy ［J］．International Journal of Aneshesiology and Rescuscitation，2019，40（8）：759-764．DOI：10.3760/cma.j.issn.1673-4378.2019.08.011.
［17］蔡华忠，秦晓梦，周峰，等．血清miRNA-155-5p和miRNA-133a-3p表达对脓毒症心肌损伤的诊断价值［J］．中国急救医学，2019，39（8）：736-738．DOI：10.3969/j.issn.1002-1949.2019.08.005.
CAI H Z，QIN X M，ZHOU F，et al．The diagnostic value of serum miRNA-155-5p，miRNA-133a-3p for myocardial injury in sepsis ［J］．Chinese Journal of Critical Care Medicine，2019，39（8）：736-738．DOI：10.3969/j.issn.1002-1949.2019.08.005.
［18］CAO C，ZHANG Y，CHAI Y F，et al．Attenuation of Sepsis-induced cardiomyopathy by regulation of MicroRNA-23b is mediated through targeting of MyD88-mediated NF-κB activation［J］．Inflammation，2019，42（3）：973-986．DOI：10.1007/s10753-019-00958-7.
［19］OCKNER R K，MANNING J A，POPPENHAUSEN R B，et al．A binding protein for fatty acids in cytosol of intestinal mucosa，liver，myocardium，and other tissues［J］．Science，1972，177（4043）：56-58．DOI：10.1126/science.177.4043.56.
［20］STORCH J，THUMSER A E A.The fatty acid transport function of fatty acid-binding proteins［J］．Biochim Biophys Acta ，2000，1486（1）：28-44．DOI：10.1016/s1388-1981（00）00046-9.
［21］ZHANG Z C，DAI H W，YU Y H，et al．Usefulness of heart-type fatty acid-binding protein in patients with severe Sepsis［J］．J Crit Care，2012，27（4）：415.e13-18．DOI：10.1016/j.jcrc.2012.01.004.
［22］YE X D，HE Y，WANG S，et al．Heart-type fatty acid binding protein（H-FABP）as a biomarker for acute myocardial injury and long-term post-ischemic prognosis［J］．Acta Pharmacol Sin，2018，39（7）：1155-1163．DOI：10.1038/aps.2018.37.
［23］KADOWAKI S，WATANABE T，OTAKI Y，et al．Combined assessment of myocardial damage and electrical disturbance in chronic heart failure［J］．World J Cardiol，2017，9（5）：457-465．DOI：10.4330/wjc.v9.i5.457.
［24］JO Y H，KIM K，LEE J H，et al．Heart-type fatty acid-binding protein as a prognostic factor in patients with severe Sepsis and septic shock［J］．Am J Emerg Med，2012，30（9）：1749-1755．DOI：10.1016/j.ajem.2012.02.005.
［25］齐洪娜，张建军，何佳起，等．心型脂肪酸结合蛋白和N-末端脑钠肽前体在脓毒症心肌损伤中的临床研究［J］．中国全科医学，2017，20（9）：1042-1048.
QI H N，ZHANG J J，HE J Q，et al． Roles for heart-type fatty acid-binding protein and n-terminal probrain natriuretic petide in myocadium injury in sepsis ［J］．Chinese General Practice，2017，20（9）：1042-1048.
［26］罗思文，张琳.h-FABP在检测脓毒症早期心肌损伤中的意义［J］．中国医药科学，2019，9（5）：89-91，95.
LUO S W，ZHANG L.Significance of h-FABP in the detection of early myocardial injury in Sepsis［J］．China Medicine and Pharmacy，2019，9（5）：89-91，95.
［27］LIN T M，GALBERT S P，KIEFER D，et al．Characterization of four human pregnancy-associated plasma proteins［J］．Am J Obstet Gynecol，1974，118（2）：223-236．DOI：10.1016/0002-9378（74）90553-5.
［28］YU X H，HE L H，GAO J H，et al．Pregnancy-associated plasma protein-A in atherosclerosis：molecular marker，mechanistic insight，and therapeutic target［J］．Atherosclerosis，2018，278：250-258．DOI：10.1016/j.atherosclerosis.2018.10.004.
［29］FUNAYAMA A，SHISHIDO T，NETSU S，et al．Serum pregnancy-associated plasma protein a in patients with heart failure［J］．J Card Fail，2011，17（10）：819-826．DOI：10.1016/j.cardfail.2011.05.011.
［30］戴海文，张召才，严静，等．脓毒症患者妊娠相关血浆蛋白A水平的变化和意义［J］．浙江医学，2009，31（1）．DOI：10.3969/j.issn.1006-2785.2009.01.009.
DAI H W，ZHANG Z C，YAN J，et al．Alteration of pregnancy-associated plasma protein A in patients with sepsis and its significance ［J］．Zhejiang Medical Journal，2009，31（1）．DOI：10.3969/j.issn.1006-2785.2009.01.009.
［31］ZHANG Z C，DAI H W，YU Y H，et al．Elevated pregnancy-associated plasma protein A predicts myocardial dysfunction and death in severe sepsis［J］．Ann Clin Biochem，2014，51（Pt 1）：22-29．DOI：10.1177/0004563213489275.
［32］AKIRA S，HEMMI H.Recognition of pathogen-associated molecular patterns by TLR family［J］．Immunol Lett，2003，85（2）：85-95．DOI：10.1016/s0165-2478（02）00228-6.
［33］KALBITZ M，GRAILER J J，FATTAHI F，et al．Role of extracellular histones in the cardiomyopathy of sepsis ［J］．FASEB J，2015，29（5）：2185-2193．DOI：10.1096/fj.14-268730.
［34］ZHANG C C，MO M H，DING W W，et al．High-mobility group box 1（HMGB1）impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum（SR）Ca2+ leak through TLR4-ROS signaling in cardiomyocytes［J］．J Mol Cell Cardiol，2014，74：260-273．DOI：10.1016/j.yjmcc.2014.06.003.
［35］ALHAMDI Y，ABRAMS S T，CHENG Z X，et al．Circulating histones are major mediators of cardiac injury in patients with sepsis［J］．Crit Care Med，2015，43（10）：2094-2103．DOI：10.1097/CCM.0000000000001162.
［36］LU N F，JIANG L，ZHU B，et al．Elevated plasma histone H4 levels are an important risk factor in the development of septic cardiomyopathy［J］．Balkan Med J，2020，37（2）：72-78．DOI：10.4274/balkanmedj.galenos.2019.2019.8.40.
［37］LU N F，ZHU B，YANG D G，et al．Elevated plasma histone is an independent risk factor for the development of septic cardiomyopathy［J］．Zhonghua Wei Zhong Bing Ji Jiu Yi Xue，2019，31（12）：1457-1461．DOI：10.3760/cma.j.issn.2095-4352.2019.12.005.
［38］张文伟，曹红，金辉.血清高迁移率族蛋白B1与脓毒症小鼠心肌细胞凋亡的相关性［J］．中国老年学杂志，2013，33（16）：3909-3910．DOI：10.3969/j.issn.1005-9202.2013.16.038.
［39］邓卓军，徐谦，苏晓清，等．血高迁移率族蛋白-1对创伤所致严重脓毒症患者心功能及预后的预测价值［J］．中华急诊医学杂志，2015，24（4）：435-437．DOI：10.3760/cma.j.issn.1671-0282.2015.04.022.
DENG Z J，XU Q，SU X Q，et al．The predicitive value of serum high mobility group box-1 protein for cardiac function and prognosis in patients with severve sepsis caused by trauma ［J］．Chinese Journal of Emergency Medicine，2015，24（4）：435-437．DOI：10.3760/cma.j.issn.1671-0282.2015.04.022.
［40］张洪齐，赵华英，杨超，等．血浆可溶性髓样细胞触发受体1对成人脓毒症患者诊断价值的Meta分析［J］．中华危重症医学杂志（电子版），2019，12（5）：328-334．DOI：10.3877/cma.j.issn.1674-6880.2019.05.008.
ZHANG H Q，ZHAO H Y，YANG C，et al．Diagnostic value of plasma solube triggering receptor expressed on myeloid cells-1 for adult patients with sepsis：a meta-analysis ［J］．Chinese Journal of Critical Care Medicine（Electronic Edition），2019，12（5）：328-334．DOI：10.3877/cma.j.issn.1674-6880.2019.05.008.
［41］TAO F，PENG L S，LI J，et al．Association of serum myeloid cells of soluble triggering receptor-1 level with myocardial dysfunction in patients with severe Sepsis［J］．Mediators Inflamm，2013，2013：819246．DOI：10.1155/2013/819246.
［42］LI Z Y，ZHANG E Y，HU Y P，et al．High serum sTREM-1 correlates with myocardial dysfunction and predicts prognosis in septic patients［J］．Am J Med Sci，2016，351（6）：555-562．DOI：10.1016/j.amjms.2016.01.023.
［43］SCHMIDT-OTT K M，MORI K，LI J Y，et al．Dual action of neutrophil gelatinase-associated lipocalin［J］．J Am Soc Nephrol，2007，18（2）：407-413．DOI：10.1681/ASN.2006080882.
［44］GOETZ D H，HOLMES M A，BORREGAARD N，et al．The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition［J］．Mol Cell，2002，10（5）：1033-1043．DOI：10.1016/s1097-2765（02）00708-6.
［45］MISHRA J，MA Q，PRADA A，et al．Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury［J］．J Am Soc Nephrol，2003，14（10）：2534-2543．DOI：10.1097/01.asn.0000088027.54400.c6.
［46］LINDBERG S，PEDERSEN S H，MOGELVANG R，et al．Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention［J］．J Am Coll Cardiol，2012，60（4）：339-345．DOI：10.1016/j.jacc.2012.04.017.
［47］YNDESTAD A，LANDR? L，UELAND T，et al．Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure［J］．Eur Heart J，2009，30（10）：1229-1236．DOI：10.1093/eurheartj/ehp088.
［48］BOLIGNANO D，BASILE G，PARISI P，et al．Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure［J］．Rejuvenation Res，2009，12（1）：7-14．DOI：10.1089/rej.2008.0803.
［49］KIRBI? S，GORENJAK M，SINKOVIC A.The role of urine neutrophil gelatinase-associated lipocalin（NGAL）in acute heart failure in patients with ST—elevation myocardial infarction［J］．BMC Cardiovasc Disord，2015，15：49．DOI：10.1186/s12872-015-0054-9.
［50］SHAPIRO N I，TRZECIAK S，HOLLANDER J E，et al．A prospective，multicenter derivation of a biomarker panel to assess risk of organ dysfunction，shock，and death in emergency department patients with suspected sepsis［J］．Crit Care Med，2009，37（1）：96-104．DOI：10.1097/CCM.0b013e318192fd9d.
［51］WANG B，CHEN G，ZHANG J，et al．Increased neutrophil gelatinase-associated lipocalin is associated with mortality and multiple organ dysfunction syndrome in severe sepsis and septic shock［J］．Shock，2015，44（3）：234-238．DOI：10.1097/SHK.0000000000000408.
［52］WANG B，CHEN G，LI J，et al．Neutrophil gelatinase-associated lipocalin predicts myocardial dysfunction and mortality in severe Sepsis and septic shock［J］．Int J Cardiol，2017，227：589-594．DOI：10.1016/j.ijcard.2016.10.096.
［53］American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference：definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis［J］．Crit Care Med，1992，20（6）：864-874.
［54］MARTIN L，DERWALL M，AL ZOUBI S，et al．The septic heart：current understanding of molecular mechanisms and clinical implications［J］．Chest，2019，155（2）：427-437．DOI：10.1016/j.chest.2018.08.1037.
［55］PEPE M S，JANES H，LONGTON G，et al．Limitations of the odds ratio in gauging the performance of a diagnostic，prognostic，or screening marker［J］．Am J Epidemiol，2004，159（9）：882-890．DOI：10.1093/aje/kwh101.
［56］JANES H，PEPE M S，GU W.Assessing the value of risk predictions by using risk stratification tables［J］．Ann Intern Med，2008，149（10）：751-760．DOI：10.7326/0003-4819-149-10-200811180-00009.
［57］PENCINA M J，D'AGOSTINO R B Sr，D'AGOSTINO R B Jr，
et al．Evaluating the added predictive ability of a new marker：from area under the ROC curve to reclassification and beyond［J］．Stat Med，2008，27（2）：157-172；discussion 207-12．DOI：10.1002/sim.2929.
［58］WANG F L，PAN W Z，PAN S M，et al．Usefulness of N-terminal pro-brain natriuretic peptide and C-reactive protein to predict ICU mortality in unselected medical ICU patients：a prospective，observational study［J］．Crit Care，2011，15（1）：R42．DOI：10.1186/cc10004.

[1]	ZHOU Qibao, LUO Xiao, CHEN Ling, CAO Junda, LI Juxiang, XU Jinsong, SU Hai. Clinical Study on the Diagnostic Value of Circadian Variability of Systolic Blood Pressure Combined with SDNN in Coronary Heart Disease [J]. Chinese General Practice, 2025, 28(30): 3760-3765.
[2]	LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778.
[3]	LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999.
[4]	SHEN Mingmei, LYU Yujiao, ZHANG Shangbo, ZHOU Xinchen, DONG Shuhan, ZHANG Zhuo, LIU Yongchao. Calcium Sensitive Receptors Mediate Signaling Pathways in Myocardial Injury [J]. Chinese General Practice, 2025, 28(18): 2301-2306.
[5]	LYU Lulu, ZHU Wanjie, XIAO Mingyang, LI Yike, ZHANG Juan. Correlation Analysis of the Circadian Rhythmicity of Blood Pressure with Ox-LDL/β2GPI Complex and Carotid Atherosclerosis in Patients with Essential Hypertension [J]. Chinese General Practice, 2025, 28(18): 2228-2233.
[6]	WANG Dexiang, YUAN Jiawen, LU Qinyun, HANG Yuhao, LU Jun, CHENG Lu. Influences of Treatment Timing of the TCM prescription Qingfei Huayu Tongfu Formula on the Therapeutic Effect and Prognosis of Sepsis-related Acute Respiratory Distress Syndrome [J]. Chinese General Practice, 2025, 28(12): 1500-1505.
[7]	LI Qiujing, SHANG Na, GAO Qian, YANG Li, GUO Shubin. Predictive Value of Abdominal CT Based-skeletal Muscle Mass Combined with Critical Illness Score for Prognosis in Older Patients with Intra-abdominal Sepsis [J]. Chinese General Practice, 2025, 28(12): 1459-1464.
[8]	JIA Shuo, CHENG Gong, GUAN Lei, FENG Panpan, XU Bailing, FANG Wei, ZHANG Ji. Diagnostic Performance of SPECT in Patients with Coronary Microcirculation Disturbance after PCI [J]. Chinese General Practice, 2025, 28(09): 1122-1127.
[9]	MA Xiaoxuan, WANG Rongqi. Research Progress in Metabolomics for HCC Diagnosis and Treatment [J]. Chinese General Practice, 2025, 28(08): 1017-1022.
[10]	ZHANG Shaotong, WANG Bo, ZHANG Mingrui, MA Guiyan, LIU Shaoguang. Identification of Sepsis Subphenotypes and Risk Stratification Using the Procalcitonin Trajectory [J]. Chinese General Practice, 2025, 28(05): 594-600.
[11]	WANG Linna, ZHANG Jinghui. Expression and Prognostic Value of Serum SAA, IL-6, TNF-α and microRNAs in Children with Sepsis Complicated with Acute Kidney Injury [J]. Chinese General Practice, 2025, 28(03): 293-298.
[12]	ZHANG Lianfang, ZHENG Yabin, LIN Xuefeng, XIE Rongcheng, MA Jiefei. Clinical Predictive Value of Immature Platelet Fraction Combined with Other Biomarkers for the Severity and Prognosis of Sepsis [J]. Chinese General Practice, 2024, 27(35): 4417-4425.
[13]	MAIERHABA· Maimaitiaili, ZHANG Kainan, ZHAO Hui, YAKUFU· Tuoheti, YE Jianwei, LYU Guodong. Investigating Serum PARP2 as a Potential Diagnostic Biomarker for Hepatocellular Carcinoma [J]. Chinese General Practice, 2024, 27(32): 4060-4065.
[14]	XIE Liying, MAI Tong, ZHOU Gengbiao, LAI Fang, HAN Yun. Analysis and Reflection on the Outcome Indicators in Clinical Trials of Traditional Chinese Medicine for Sepsis-induced Acute Lung Injury/Acute Respiratory Distress Syndrome [J]. Chinese General Practice, 2024, 27(27): 3418-3427.
[15]	CHEN Wensheng, LIU Wenming. Research Progress on the Role of Gut Microbiota in the Pathogenesis and Treatment of Sepsis-associated Liver Injury [J]. Chinese General Practice, 2024, 27(21): 2665-2671.